Skip to content
HowShorted

Medifast, Inc. short interest in 2025

In 2025, Medifast, Inc.'s disclosed short interest ran from 12.84% of shares outstanding on 15 Jan 2025 to 17.95% on 31 Dec 2025, a change of +5.11 percentage points. The year's high was 21.28% on 15 Sep 2025 and its low 10.51% on 30 Apr 2025, averaging 15.89% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 18.42 days on 15 Sep 2025. Full history: Medifast, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for Medifast, Inc. in 2025

2025 in figures

Start of year
12.84% (15 Jan 2025)
End of year
17.95% (31 Dec 2025)
Change
+5.11 pp
High
21.28% (15 Sep 2025)
Low
10.51% (30 Apr 2025)
Average
15.89%
Highest days to cover
18.42 (15 Sep 2025)
SEC filings marked
8

Every report in 2025

Medifast, Inc. short interest in 2025
SettlementShort interestDays to coverFilings since previous
15 Jan 202512.84%6.23
31 Jan 202512.56%6.60
14 Feb 202512.28%6.78
28 Feb 202512.75%4.6010-K filed, results (8-K)
14 Mar 202511.81%6.25
31 Mar 202512.64%6.90
15 Apr 202510.96%4.25
30 Apr 202510.51%5.6310-Q filed, results (8-K)
15 May 202512.75%6.76
30 May 202512.11%6.04
13 Jun 202515.02%7.19
30 Jun 202517.14%5.55
15 Jul 202520.26%12.15
31 Jul 202520.83%10.44
15 Aug 202518.53%9.7510-Q filed, results (8-K)
29 Aug 202518.80%11.06
15 Sep 202521.28%18.42
30 Sep 202519.02%12.72
15 Oct 202518.97%16.99
31 Oct 202518.56%11.75
14 Nov 202518.75%11.4010-Q filed, results (8-K)
28 Nov 202516.87%8.45
15 Dec 202518.14%7.19
31 Dec 202517.95%6.39

See also: Medifast, Inc.'s full history · most shorted US stocks of 2025 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.